Plant Comparison

Astragalus vs Field restharrow

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AAstragalusAstragalus membranaceusFabaceaeFull monograph →
Plant BField restharrowOnonis arvensisFabaceaeFull monograph →

At a glance

Astragalus and Field restharrow: both belong to the Fabaceae family; they share 5 indicated uses (cancer (anticancer research), infection (general), inflammation (general), …); 3 pharmacological actions in common.

AstragalusField restharrow
Constituents36
Pharmacological actions612
Indicated uses1011
Safety notes33
Cited sources1842
Indicated uses
Only Astragalus
Arthritis / joint painCold & fluFatigue / low energyImmune supportStress
Shared (5)
Cancer (anticancer research)Infection (general)Inflammation (general)Kidney supportSkin irritation
Only Field restharrow
Urinary supportUrinary tract infection (UTI)Swelling / fluid retentionWoundsPain (general)Cardiovascular / heart health
Pharmacological actions
Only Astragalus
AdaptogenImmunomodulator / immune supportNephroprotective (kidney support)
Shared (3)
Anti-inflammatoryAnticancer (preclinical)Antioxidant
Only Field restharrow
DiureticUrinary antisepticAntimicrobialVulnerary (wound healing)Analgesic (pain relief)GastroprotectiveAntifungalLipid-loweringAntiplatelet / anticoagulant

Evidence face-off — shared uses

ConditionAstragalusField restharrowVerdict
Cancer (anticancer research)2/102/10Comparable evidence
Infection (general)2/102/10Comparable evidence
Inflammation (general)1/102/10Comparable evidence
Kidney support7/107/10Comparable evidence
Skin irritation1/102/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Astragalus polysaccharides (APS)[11]

Principal immunomodulatory constituents.

Polysaccharides
Cycloartane triterpenoid saponins (astragaloside IV)[5]

Major bioactive saponin with cardio-, neuro-, hepato- and renoprotective effects.

Saponins
Isoflavonoids (calycosin, formononetin)[5]

Antioxidant flavonoid constituents of the root.

Flavonoids
Isoflavonoids (formononetin, ononin and derivatives)[1, 3, 5, 20]

Formononetin and its 7-O-glucoside ononin, plus related isoflavones - the signature restharrow constituents (also phytoestrogens).

FlavonoidsGlycosidesPhenolic compounds
Pterocarpans and isoflavanones (medicarpin, maackiain, onogenin, sativanone)[1, 4]

Pterocarpans and isoflavanones and their glucosides, contributing to antimicrobial and wound-healing activity.

FlavonoidsGlycosides
alpha-Onocerin[7]

alpha-Onocerin (onocerin), a characteristic triterpene of the genus Ononis.

Triterpene saponinsTerpenes / terpenoids
Coumarins (scopoletin, scopolin)[1]

Coumarins detected in the phytochemical profile.

Coumarins
Hydroxycinnamic / phenolic acids[6]

Caffeic, chlorogenic and p-coumaric acids (antioxidant).

Caffeic acidChlorogenic acidPhenolic acids
Essential (volatile) oil[10]

A volatile oil present in the root and aerial parts.

Essential (volatile) oil

Pharmacological Actions

Adaptogen[5, 10]

Adaptogenic tonic for fatigue and low vitality (traditional 'Qi' tonic)

Anti-inflammatory[2, 5, 7]

Antioxidant and anti-inflammatory

Anticancer (preclinical)[2, 5, 11, 15, 16, 17]

Astragalus membranaceus and its constituents (astragaloside IV, cycloastragenol, Astragalus polysaccharide) inhibit tumour growth, invasion and metastasis and enhance antitumour immunity across lung, colorectal and gastrointestinal cancers (preclinical, incl. in vivo).

Antioxidant[4, 5, 9]

Antioxidant and anti-inflammatory

Immunomodulator / immune support[2, 4, 5, 6, 11, 12, 13]

Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes)

Nephroprotective (kidney support)[5, 18]

Renoprotective (kidney support) - as an adjunct in chronic kidney disease, reduced proteinuria and raised haemoglobin and serum albumin across trials (Cochrane review; study quality low)

Diuretic[8, 13, 28, 30, 42]

Aquaretic diuretic; the classic irrigation-therapy action of restharrow root (Ononidis radix), used interchangeably for O. arvensis and O. spinosa.

Urinary antiseptic[15]

Aqueous root extract reduced adhesion of uropathogenic E. coli to bladder cells (anti-adhesive).

Anti-inflammatory[14, 16, 17, 39]

Inhibits IL-8 release via TLR4/LPS and cytosolic phospholipase A2alpha (restharrow root).

Antimicrobial[2, 13, 21, 41]
Vulnerary (wound healing)[16, 20]

Isoflavonoids from restharrow root promote wound healing in vivo.

Antioxidant[5, 6, 13, 21, 31, 34, 40]
Analgesic (pain relief)[18, 33]

Analgesic activity of Ononis extract in animals (congener O. spinosa).

Gastroprotective[19]

Protective against ethanol-induced gastric mucosal injury (congener O. spinosa).

Anticancer (preclinical)[5, 27]

Ononis isoflavones showed chemopreventive/antiproliferative activity against breast cancer cells (preclinical).

Antifungal[22]
Lipid-lowering[24, 35]
Antiplatelet / anticoagulant[26]

Traditional & Indicated Uses

Arthritis / joint pain[5]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cancer (anticancer research)[2, 5, 11, 15, 16, 17]Traditional · 2/10

Astragalus membranaceus protects against gastrointestinal cancers; astragaloside IV inhibits lung cancer metastasis via macrophage repolarization, cycloastragenol boosts CD8+ T-cell antitumour immunity (with anti-PD-1 synergy), and Astragalus polysaccharide suppresses inflammation-induced colorectal cancer (preclinical).

Evidence: 2
Label: Cancer (anticancer research)
Cold & flu[11]Traditional · 2/10

Supports resistance to colds and respiratory infection (immune)

Evidence: 2
Label: Cold & flu
Fatigue / low energy[5]Traditional · 1/10

Adaptogenic tonic for fatigue and low vitality (traditional 'Qi' tonic)

Evidence: 1
Label: Fatigue / low energy
Immune support[5, 11]Traditional · 2/10

Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes); Supports resistance to colds and respiratory infection (immune)

Evidence: 2
Label: Immune support
Infection (general)[11]Traditional · 2/10

Supports resistance to colds and respiratory infection (immune)

Evidence: 2
Label: Infection (general)
Inflammation (general)[5]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Kidney support[5, 18]Good · 7/10

Renoprotective (kidney support) - as an adjunct in chronic kidney disease, reduced proteinuria and raised haemoglobin and serum albumin across trials (Cochrane review; study quality low)

Evidence: 7
Label: Kidney support
Skin irritation[5]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Stress[5]Traditional · 1/10

inferred from adaptogen action

Evidence: 1
Label: Stress
Cancer (anticancer research)[5, 27]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Urinary support[8, 13, 15, 28, 30]Strong · 9/10

Aquaretic diuretic for irrigation therapy of the urinary tract.

Evidence: 9
Label: Urinary support
Urinary tract infection (UTI)[15]Traditional · 2/10

Anti-adhesive activity against uropathogenic E. coli.

Evidence: 2
Label: Urinary tract infection (UTI)
Kidney support[8, 13]Good · 7/10

inferred from diuretic / urinary 'gravel' traditional use

Evidence: 7
Label: Kidney support
Swelling / fluid retention[13]Good · 7/10

inferred from diuretic (aquaretic) action

Evidence: 7
Label: Swelling / fluid retention
Infection (general)[2]Traditional · 2/10

inferred from antimicrobial action

Evidence: 2
Label: Infection (general)
Wounds[16]Traditional · 2/10

Isoflavonoid wound-healing agents from restharrow root.

Evidence: 2
Label: Wounds
Skin irritation[8, 17]Traditional · 2/10

inferred from anti-inflammatory and traditional skin/eczema use

Evidence: 2
Label: Skin irritation
Inflammation (general)[14, 17]Traditional · 2/10
Evidence: 2
Label: Inflammation (general)
Pain (general)[18]Traditional · 2/10

inferred from analgesic action

Evidence: 2
Label: Pain (general)
Cardiovascular / heart health[24, 26, 35]Traditional · 2/10

Ononis isoflavonoids (maackiain, ononin) showed anti-adipogenic activity via PPAR-gamma inhibition (preclinical).

Evidence: 2
Label: Cardiovascular / heart health

Safety, Cautions & Contraindications

Safety note[11]Info

Astragalus stimulates immune activity; on theoretical grounds it should be used cautiously in autoimmune disease and with immunosuppressant medicines (for example after organ transplant) - discuss with a clinician.

Safety note[5]Info

Generally well tolerated; high-quality long-term human safety and toxicity data remain limited.

Safety note[5]Caution

Safety in pregnancy and breastfeeding has not been established; avoid medicinal doses.

Safety note[18]Warning

A safety signal exists in the genus: an Ononis spinosa root extract showed hepatotoxic effects at higher doses in animals (alongside analgesic activity). Avoid excessive or prolonged use, and use caution in liver disease.

Safety note[13]Caution

Used as an aquaretic for irrigation therapy of the urinary tract, restharrow should be taken with a generous fluid intake; it should NOT be used for 'flushing' when there is oedema due to impaired heart or kidney function (standard irrigation-therapy caution).

Safety note[1, 3]Caution

The root is rich in isoflavone phytoestrogens (formononetin); avoid medicinal doses in pregnancy and breastfeeding and use caution in hormone-sensitive conditions.

External Ids

Gbif: 2933951
Powo: urn:lsid:ipni.org:names:478610-1
Wikidata: Q15532251
Gbif: 2977171
Wikidata: Q164263

Botanical Description

Erect perennial herb with a long, fibrous, pale yellow taproot. The leaves are pinnately compound with numerous small, oval leaflets, giving a soft, ferny appearance. Small, pale yellow, pea-like flowers are borne in loose axillary clusters (racemes), followed by membranous, inflated seed pods that give the species its name.[5]

Height: 40-100 cm
Habit: Erect perennial herb
Leaves: Pinnately compound with numerous small, oval leaflets
Flowers: Small, pale yellow, pea-like flowers in loose axillary racemes
Stem: Erect, softly hairy
Root: Long, fibrous, pale yellow taproot (the medicinal part, huang qi)
Fruit: Membranous, inflated seed pod
Flowering Period: June-July

A tough, deep-rooted perennial herb or low subshrub of the pea family, 30-80 cm tall, sometimes bearing soft spines. It has a very long, woody, tenacious taproot - so strong it was said to stop (arrest) the harrow, giving 'rest-harrow' its name. The stems are hairy and sticky, often reddish, and clothed in small trifoliolate (clover-like) leaves with toothed leaflets. The flowers are typical pea flowers, pink to purplish-pink (occasionally white), borne singly or in pairs in the leaf axils. Field restharrow (O. arvensis) is generally less spiny than its close relative spiny restharrow (O. spinosa).[8, 10]

Height: 30-80 cm
Habit: Deep-rooted perennial herb or low subshrub, sometimes softly spiny
Leaves: Trifoliolate (clover-like), with finely toothed leaflets; stems hairy and glandular-sticky
Flowers: Pea-type, pink to purplish-pink (rarely white), solitary or paired in the leaf axils
Stem: Erect to ascending, hairy and sticky, often reddish; less spiny than O. spinosa
Root: Very long, woody, tenacious taproot (the medicinal Ononidis radix)
Fruit: A small, hairy, few-seeded pea pod
Flowering Period: June-September

Habitat

Native to the grasslands, sunny slopes and forest margins of northern and north-eastern China, Mongolia and parts of Korea; widely cultivated as a medicinal crop across East Asia.[5]

Rough grassland, field margins, roadsides, dunes and dry, sandy or calcareous waste ground across Europe, western Asia and parts of North Africa. As a deep-rooted, nitrogen-fixing legume it colonises poor, disturbed soils and was historically a troublesome weed of arable fields (hence 'restharrow').[8]

Harvesting

The root is dug from plants at least four years old, typically in spring or autumn, then cleaned and dried, often sliced into the characteristic pale, fibrous 'coin' slices used in traditional decoctions.[5]

Parts: Root
Season: Spring or autumn, from four-year-old (or older) plants

The root (Ononidis radix) is the principal medicinal part, dug in autumn from the second year onward and dried; the aerial flowering parts are also gathered in summer. The long woody taproot is cleaned and cut before drying for decoctions and infusions.[8]

Parts: Root, Aerial parts
Season: Root in autumn; aerial parts in flower (summer)

Traditional Uses

Astragalus root (huang qi) is one of the most widely used tonic herbs in traditional Chinese medicine, classified as a 'Qi tonic' for fatigue, low vitality and reduced resistance to colds and infections, and used to support immune, cardiovascular and kidney health.[5, 11]

Restharrow root has a long place in European herbal medicine as a gentle aquaretic diuretic used for 'irrigation therapy' of the urinary tract - to increase urine flow in cystitis, urinary gravel and stones, and to flush the bladder. Field restharrow (Ononis arvensis) is used interchangeably with the officinal spiny restharrow (O. spinosa, Ononidis radix). The root and flowering herb have also been used as a mild anti-inflammatory, for skin complaints and eczema, for rheumatic conditions, and (as a decoction or gargle) for the mouth and throat. The isoflavone-rich root is a folk remedy in central and eastern European traditions.[8, 13]

Preparations

Decoction[5]

Dried, sliced root simmered in water, often alongside other tonic herbs, as the classic traditional Chinese medicine preparation.

Standardised extract[5, 11]

Concentrated extract standardised to polysaccharide or astragaloside IV content, taken as capsules or tablets.

Decoction[8, 13]

The dried root simmered in water and taken as an aquaretic diuretic for irrigation of the urinary tract; the classic restharrow preparation.

Infusion[8]

The flowering aerial parts infused as a milder diuretic and anti-inflammatory tea.

Gargle / wash[8]

A root decoction used traditionally as a mouth/throat gargle and as a wash for skin complaints.

Dosage

Decoction[14]

The WHO monograph on Radix Astragali gives doses of 3-9 g per day. Traditional Chinese medicine references often cite a considerably higher 9-30 g of dried root per day; WHO's figure is the conservative regulatory-tier one and is stated here in preference. Educational reference only, not a prescription.

Standardised extract[11]

Clinical studies commonly use extracts providing the equivalent of several grams of dried root daily, in divided doses. Educational reference only, not a prescription.

Not documented

References

REF-0739, REF-0736, REF-0737, REF-2256, REF-0402, REF-2257, REF-2258, REF-2259, REF-2260, REF-2261, REF-0401, REF-2262, REF-2263
REF-2741, REF-2742, REF-2743, REF-2744, REF-2745, REF-2746, REF-2747, REF-2748, REF-2749, REF-2750, REF-2751, REF-2752, REF-2753, REF-2754, REF-2755, REF-2756, REF-2757, REF-2758, REF-2759, REF-2760, REF-3015, REF-3016, REF-3017, REF-3018, REF-3019, REF-3020, REF-3021, REF-3022, REF-3023, REF-3024, REF-3025, REF-3026, REF-3027, REF-3028, REF-3029, REF-3030, REF-3031, REF-3032, REF-3033, REF-3034, REF-3035, REF-3036

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

[8]

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Synonyms

Not documented

Ononis hircina, Ononis arvensis subsp. arvensis

Drug Class Interactions

Not documented

Safety note[8, 13]Caution
Drug Class: diuretics
Mechanism: Restharrow is an aquaretic diuretic; taken with pharmaceutical diuretics it may add to fluid and electrolyte loss.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10
Safety note[1, 3]Caution
Drug Class: hormonal-therapies
Mechanism: The root is rich in the isoflavone phytoestrogen formononetin; it could theoretically interact with hormonal contraceptives, hormone replacement or hormone-sensitive conditions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Pairings

Not documented

Classic urinary irrigation-therapy pairing: both are aquaretic diuretics used to increase urine flow in cystitis and urinary gravel.[13]

Partner Id: solidago-virgaurea
Type: synergy
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Both are traditional diuretic 'flushing' herbs for irrigation therapy of the urinary tract.[13]

Partner Id: betula-pendula
Type: synergy
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Both are Fabaceae rich in the isoflavone phytoestrogen formononetin; combined use adds to phytoestrogen exposure - use caution in hormone-sensitive conditions.[1]

Partner Id: trifolium-pratense
Type: caution
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

References & Sources

  1. Xu, B., Huang, J.P., Peng, G., Cao, W., Liu, Z. et al (2024) 'Total biosynthesis of the medicinal triterpenoid saponin astragalosides', Nature Plants, 10(11), pp. 1826-1837. doi:10.1038/s41477-024-01827-4 Preclinical
    https://doi.org/10.1038/s41477-024-01827-4
  2. Auyeung, K.K., Han, Q.B. and Ko, J.K (2016) 'Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers', The American Journal of Chinese Medicine, 44(1), pp. 1-22. doi:10.1142/S0192415X16500014 Traditional / reference
    https://doi.org/10.1142/S0192415X16500014
  3. Zhang, Y., Ji, W., Qin, H., Chen, Z., Zhou, Y. et al (2024) 'Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent manner', Carbohydrate Polymers, 349, pp. 122829. doi:10.1016/j.carbpol.2024.122829 Preclinical
    https://doi.org/10.1016/j.carbpol.2024.122829
  4. Fu, J., Wang, Z., Huang, L., Zheng, S., Wang, D., Chen, S., Zhang, H. and Yang, S (2014) 'Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)', Phytotherapy Research, 28(9), pp. 1275-1283. doi:10.1002/ptr.5188 Meta-analysis / review
    https://doi.org/10.1002/ptr.5188
  5. Zhang, J., Wu, C., Gao, L., Du, G. and Qin, X (2019) 'Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects', Advances in Pharmacology. doi:10.1016/bs.apha.2019.08.002 Traditional / reference
    https://doi.org/10.1016/bs.apha.2019.08.002
  6. Dong, M., Li, J., Yang, D., Li, M. and Wei, J (2023) 'Biosynthesis and pharmacological activities of flavonoids, triterpene saponins and polysaccharides derived from Astragalus membranaceus', Molecules, 28(13), pp. 5018. doi:10.3390/molecules28135018 Meta-analysis / review
    https://doi.org/10.3390/molecules28135018
  7. Chen, G., Jiang, N., Zheng, J., Hu, H., Yang, H., Lin, A., Hu, B. and Liu, H (2023) 'Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 241, pp. 124386. doi:10.1016/j.ijbiomac.2023.124386 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2023.124386
  8. Zheng, Q., Zhuang, Z., Wang, Z., Deng, L., Jin, W., Huang, Z., Zheng, G. and Wang, Y (2020) 'Clinical and preclinical systematic review of Astragalus membranaceus for viral myocarditis', Oxidative Medicine and Cellular Longevity, 2020, pp. 1560353. doi:10.1155/2020/1560353 Meta-analysis / review
    https://doi.org/10.1155/2020/1560353
  9. Dai, Y., Wang, Y., Kang, Q., Wu, Y., Liu, Y., Su, Y., Wang, X., Xiu, M. and He, J (2024) 'The protective effect and bioactive compounds of Astragalus membranaceus against neurodegenerative disorders via alleviating oxidative stress in Drosophila', FASEB Journal, 38(13), pp. e23727. doi:10.1096/fj.202400390R Preclinical
    https://doi.org/10.1096/fj.202400390R
  10. Xu, L., Xu, X., Hou, X., Wang, F., Gao, S. and Zhang, H (2019) 'Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review', Metabolic Brain Disease, 35(1), pp. 83-93. doi:10.1007/s11011-019-00483-4 Meta-analysis / review
    https://doi.org/10.1007/s11011-019-00483-4
  11. Li, C.X., Liu, Y., Zhang, Y.Z., Li, J.C. and Lai, J (2022) 'Astragalus polysaccharide: a review of its immunomodulatory effect', Archives of Pharmacal Research. doi:10.1007/s12272-022-01393-3 Preclinical
    https://doi.org/10.1007/s12272-022-01393-3
  12. Jin, M., Zhao, K., Huang, Q. and Shang, P (2014) 'Structural features and biological activities of the polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 64, pp. 257-266. doi:10.1016/j.ijbiomac.2013.12.002 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2013.12.002
  13. Liu, Y. and Lv, W (2019) 'Research progress in Astragalus membranaceus and its active components on immune responses in liver fibrosis', Chinese Journal of Integrative Medicine, 26(10), pp. 794-800. doi:10.1007/s11655-019-3039-1 Meta-analysis / review
    https://doi.org/10.1007/s11655-019-3039-1
  14. World Health Organization (1999) 'Radix Astragali'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
    https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37
  15. Xu, F. and Cui, W.-Q. and Wei, Y. and Cui, J. and Qiu, J. and Hu, L.-L. and Gong, W.-Y. and Dong, J.-C. and Liu, B.-J (2018) 'Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling', Journal of Experimental & Clinical Cancer Research, 37(1), pp. 207. doi:10.1186/s13046-018-0878-0 Preclinical
    https://doi.org/10.1186/s13046-018-0878-0
  16. Deng, G. and Zhou, L. and Wang, B. and Sun, X. and Zhang, Q. and Chen, H. and Wan, N. and Ye, H. and Wu, X. and Sun, D. and Sun, Y. and Cheng, H (2022) 'Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation', Journal for ImmunoTherapy of Cancer, 10(10), pp. e004874. doi:10.1136/jitc-2022-004874 Preclinical
    https://doi.org/10.1136/jitc-2022-004874
  17. Li, Q. and Zhang, C. and Xu, G. and Shang, X. and Nan, X. and Li, Y. and Liu, J. and Hong, Y. and Wang, Q. and Peng, G (2024) 'Astragalus polysaccharide ameliorates CD8 T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation-induced colorectal cancer', Biomedicine & Pharmacotherapy, 171, pp. 116172. doi:10.1016/j.biopha.2024.116172 Preclinical
    https://doi.org/10.1016/j.biopha.2024.116172
  18. Zhang, H.W., Lin, Z.X., Xu, C., Leung, C. and Chan, L.S (2014) 'Astragalus (a traditional Chinese medicine) for treating chronic kidney disease', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008369.pub2 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD008369.pub2
  1. Gampe, N. and Darcsi, A. and Nagyne Nedves, A. and Boldizsar, I. and Kursinszki, L. and Beni, S (2019) 'Phytochemical analysis of Ononis arvensis L. by liquid chromatography coupled with mass spectrometry', Journal of Mass Spectrometry, 54(2), pp. 121-133. doi:10.1002/jms.4308 Preclinical
    https://doi.org/10.1002/jms.4308
  2. Denes, T. and Bartha, S.G. and Kerenyi, M. and Varga, E. and Balazs, V.L. and Csepregi, R. and Papp, N (2017) 'Histological and antimicrobial study of Ononis arvensis L', Acta Biologica Hungarica, 68(3), pp. 321-333. doi:10.1556/018.68.2017.3.9 Preclinical
    https://doi.org/10.1556/018.68.2017.3.9
  3. Gampe, N. and Nagy, E. and Kursinszki, L. and Beni, S (2021) 'Quantitative determination of isoflavonoids in Ononis species by UPLC-UV-DAD', Phytochemical Analysis, 32(4), pp. 474-481. doi:10.1002/pca.2995 Preclinical
    https://doi.org/10.1002/pca.2995
  4. Gampe, N. and Szakacs, Z. and Darcsi, A. and Boldizsar, I. and Szoke, E. and Kuzovkina, I. and Kursinszki, L. and Beni, S (2021) 'Qualitative and Quantitative Phytochemical Analysis of Ononis arvensis Hairy Root Cultures', Frontiers in Plant Science, 11, pp. 622585. doi:10.3389/fpls.2020.622585 Preclinical
    https://doi.org/10.3389/fpls.2020.622585
  5. Pazdziora, W. and Grabowska, K. and Zagrodzki, P. and Pasko, P. and Prochownik, E. and Podolak, I. and Galanty, A (2025) 'Quantitative Analysis of Isoflavones from Ononis Species and Their Chemopreventive Potential on Breast Cancer Cells', Molecules, 30(11), pp. 2379. doi:10.3390/molecules30112379 Preclinical
    https://doi.org/10.3390/molecules30112379
  6. Spilkova, J. and Bednar, P. and Stroblikova, R (2001) 'Capillary electrophoretic analysis of hydroxycinnamic acids from Ononis arvensis L', Die Pharmazie, 56(5), pp. 424-425. Preclinical
    https://scholar.google.com/scholar?q=Capillary%20electrophoretic%20analysis%20of%20hydroxycinnamic%20acids%20from%20Ononis%20arvensis%20L.
  7. Spilkova, J. and Hubik, J (1982) 'Pharmacognosy study of Ononis arvensis L. II. Flavonoids and onocerin in the drug', Ceskoslovenska Farmacie, 31(1), pp. 24-26. Preclinical
    https://scholar.google.com/scholar?q=Pharmacognosy%20study%20of%20Ononis%20arvensis%20L.%20II.%20Flavonoids%20and%20onocerin%20in%20the%20drug
  8. Rezacova, A. and Spilkova, J. and Hubik, J (1978) 'A pharmacognostic study of the species Ononis arvensis L', Ceskoslovenska Farmacie, 27(10), pp. 452-455. Traditional / reference
    https://scholar.google.com/scholar?q=A%20pharmacognostic%20study%20of%20the%20species%20Ononis%20arvensis%20L.
  9. Felsberg, A.A. and Rosentsveig, P.E (1965) 'A comparative phytochemical study of the roots of Ononis arvensis L. and Ononis spinosa L', Aptechnoe Delo, 14(6), pp. 26-32. Preclinical
    https://scholar.google.com/scholar?q=A%20comparative%20phytochemical%20study%20of%20the%20roots%20of%20Ononis%20arvensis%20L.%20and%20Ononis%20spinosa%20L.
  10. Sichinava, M.B. and Mchelidze, K.Z. and Churadze, M.V. and Alaniia, M.D. and Aneli, D.N (2014) 'Chemical composition and microstructural peculiarities of overground and underground vegetative organs of field restharrow (Ononis arvensis L.)', Georgian Medical News, (231), pp. 88-94. Preclinical
    https://scholar.google.com/scholar?q=Chemical%20composition%20and%20microstructural%20peculiarities%20of%20overground%20and%20underground%20vegetative%20organs%20of%20field%20restharrow%20%28Ononis%20arvensis%20L.%29
  11. Dedio, I. and Kozlowski, J (1977) 'Comparative morphological and phytochemical studies of Ononis spinosa L. and Ononis arvensis L. I. Biometric and chromatographic studies of methanolic extracts', Acta Poloniae Pharmaceutica, 34(1), pp. 97-102. Preclinical
    https://scholar.google.com/scholar?q=Comparative%20morphological%20and%20phytochemical%20studies%20of%20Ononis%20spinosa%20L.%20and%20Ononis%20arvensis%20L.%20I.%20Biometric%20and%20chromatographic%20studies%20of%20methanolic%20extracts
  12. Felsberg, A.A. and Rozentsveig, P.E (1965) 'Photochemical examination of Ononis arvensis. I', Aptechnoe Delo, 14(3), pp. 25-27. Preclinical
    https://scholar.google.com/scholar?q=Photochemical%20examination%20of%20Ononis%20arvensis.%20I
  13. Nechita, V. and Tarau, A. and Suster, A. and Nechita, M. and Toiu, A. and Benedec, D. and Hanganu, D. and Siserman, C. and Drugan, C. and Oniga, I (2026) 'Phytochemical Constituents and Biological Activities of Ononis spinosa: A Comprehensive Review', Plants (Basel), 15(9), pp. 1409. doi:10.3390/plants15091409 Meta-analysis / review
    https://doi.org/10.3390/plants15091409
  14. Spiegler, V. and Gierlikowska, B. and Saenger, T. and Addotey, J.N. and Sendker, J. and Jose, J. and Kiss, A.K. and Hensel, A (2020) 'Root Extracts From Ononis spinosa Inhibit IL-8 Release Via Interactions With Toll-Like Receptor 4 and Lipopolysaccharide', Frontiers in Pharmacology, 11, pp. 889. doi:10.3389/fphar.2020.00889 Preclinical
    https://doi.org/10.3389/fphar.2020.00889
  15. Deipenbrock, M. and Sendker, J. and Hensel, A (2020) 'Aqueous Root Extract from Ononis spinosa Exerts Anti-adhesive Activity against Uropathogenic Escherichia coli', Planta Medica, 86(4), pp. 247-254. doi:10.1055/a-1089-8645 Preclinical
    https://doi.org/10.1055/a-1089-8645
  16. Ergene Oz, B. and Saltan Iscan, G. and Kupeli Akkol, E. and Suntar, I. and Bahadir Acikara, O (2017) 'Isoflavonoids as wound healing agents from Ononidis Radix', Journal of Ethnopharmacology, 211, pp. 384-393. doi:10.1016/j.jep.2017.09.029 Preclinical
    https://doi.org/10.1016/j.jep.2017.09.029
  17. Arnold, E. and Benz, T. and Zapp, C. and Wink, M (2015) 'Inhibition of Cytosolic Phospholipase A2alpha (cPLA2alpha) by Medicinal Plants in Relation to Their Phenolic Content', Molecules, 20(8), pp. 15033-15048. doi:10.3390/molecules200815033 Preclinical
    https://doi.org/10.3390/molecules200815033
  18. Yilmaz, B.S. and Ozbek, H. and Citoglu, G.S. and Ugras, S. and Bayram, I. and Erdogan, E (2006) 'Analgesic and hepatotoxic effects of Ononis spinosa L', Phytotherapy Research, 20(6), pp. 500-503. doi:10.1002/ptr.1891 Preclinical
    https://doi.org/10.1002/ptr.1891
  19. Manal Ahmad, A. and Yasser Ibrahim, K. and Manal Mohammad, A (2021) 'Efficacy of extract from Ononis spinosa L. on ethanol-induced gastric mucosal injury in rats', Journal of Traditional Chinese Medicine, 41(2), pp. 270-275. Preclinical
    https://scholar.google.com/scholar?q=Efficacy%20of%20extract%20from%20Ononis%20spinosa%20L.%20on%20ethanol-induced%20gastric%20mucosal%20injury%20in%20rats
  20. Addotey, J.N. and Lengers, I. and Jose, J. and Gampe, N. and Beni, S. and Petereit, F. and Hensel, A (2018) 'Isoflavonoids with inhibiting effects on human hyaluronidase-1 and norneolignan clitorienolactone B from Ononis spinosa L. root extract', Fitoterapia, 130, pp. 169-174. doi:10.1016/j.fitote.2018.08.013 Preclinical
    https://doi.org/10.1016/j.fitote.2018.08.013
  21. Stojković, D. and Drakulić, D. and Gašić, U. and Zengin, G. and Stevanović, M. and Rajčević, N. and Sokóvić, M (2020) 'Ononis spinosa L., an edible and medicinal plant: UHPLC-LTQ-Orbitrap/MS chemical profiling and biological activities of the herbal extract', Food & Function. doi:10.1039/d0fo01595d Preclinical
    https://doi.org/10.1039/d0fo01595d
  22. Stojković, D. and Días, M.I. and Drakulić, D. and Barros, L. and Stevanović, M. and Ferreira, I.C. and Sokóvić, M (2020) 'Methanolic Extract of the Herb Ononis spinosa L. Is an Antifungal Agent with no Cytotoxicity to Primary Human Cells', Pharmaceuticals. doi:10.3390/ph13040078 Preclinical
    https://doi.org/10.3390/ph13040078
  23. Kırmızıgül, S. and Gören, N. and Yang, S. and Cordell, G.A. and Bozok-Johansson, C (1997) 'Spinonin, a Novel Glycoside from Ononis spinosa subsp. leiosperma', Journal of Natural Products. doi:10.1021/np9605652 Preclinical
    https://doi.org/10.1021/np9605652
  24. Mladenova, S.G. and Savova, M.S. and Marchev, A.S. and Ferrante, C. and Orlando, G. and Wabitsch, M. and Georgiev, M.I (2022) 'Anti-adipogenic activity of maackiain and ononin is mediated via inhibition of PPARγ in human adipocytes', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2022.112908 Preclinical
    https://doi.org/10.1016/j.biopha.2022.112908
  25. Лужанин, В.Г. and Whaley, A.K. and Ponkratova, A.O. and Grishukova, E.A. and Suloev, I.S. and Смирнов, С.Н. and Serebryakov, E.B (2021) 'Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L', Drug development & registration. doi:10.33380/2305-2066-2021-10-1-83-89 Preclinical
    https://doi.org/10.33380/2305-2066-2021-10-1-83-89
  26. Bogoutdinova, A. and Whaley, A.K. and Ponkratova, A.O. and Orlova, A. and Goncharov, M.Y. and Shpakova, V. and Farmanova, N.T. and Nurullaeva, D.K. and Sharipov, A. and Gambaryan, S. and Повыдыш, М.Н (2021) 'Isolation of formononetin-7-O-β-D-glucopyranoside from the grass of Ononis arvensis L. and the assessment of its effect on induced platelet activation', Drug development & registration. doi:10.33380/2305-2066-2021-10-4(1)-14-19 Preclinical
    https://doi.org/10.33380/2305-2066-2021-10-4(1)-14-19
  27. Paździora, W. and Grabowska, K. and Paśko, P. and Prochownik, E. and Podolak, I. and Galanty, A (2026) 'Multifaceted Evaluation of Isoflavone-Rich Fabaceae Species in Prostate Cancer In Vitro Models', Applied Sciences. doi:10.3390/app16136289 Preclinical
    https://doi.org/10.3390/app16136289
  28. Gallo, G. and Cicione, A. and Nacchia, A. and Lombardo, R. and Riolo, S. and Guercio, A. and Fiasconaro, D. and Nunzio, C.D (2026) 'A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms', Urologia Journal. doi:10.1177/03915603261454171 Randomized trial
    https://doi.org/10.1177/03915603261454171
  29. Ismailov, E. and Рогожникова, Е. and Марданлы, С.Г. and Мизина, П. and Kalinina, T.S (2024) 'COMPARATIVE STUDY OF SETTINGS FROM WILD SPECIES OF STEELWORM', Problems of Biological Medical and Pharmaceutical Chemistry. doi:10.29296/25877313-2024-12-02 Preclinical
    https://doi.org/10.29296/25877313-2024-12-02
  30. Mauro, E.D. and Saldutto, P. and Rocca, R.L. and Sangiorgi, G. and Patelli, G. and Barone, B. and Verratti, V. and Castellucci, R. and Napolitano, L. and Iacono, F. and Altieri, V (2024) 'Efficacy and Safety of Boldine Combined with Phyllanthus niruri and Ononis spinosa in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Single-Center, Retrospective Cohort Study', Medicina. doi:10.3390/medicina60091455 Clinical study
    https://doi.org/10.3390/medicina60091455
  31. DÉNES, T (2022) 'PHYTOCHEMICAL INVESTIGATION AND ANTIOXIDANT POTENTIAL OF ONONIS ARVENSIS L', FARMACIA. doi:10.31925/farmacia.2022.3.20 Preclinical
    https://doi.org/10.31925/farmacia.2022.3.20
  32. Zarga, M.H.A. and Al‐Jaber, H.I. and Al‐Qudah, M.A. and Al-Aboudi, A.M (2021) 'A new cyclic polyketide and other constituents from Ononis spinosa growing wildly in Jordan and their antioxidant activity', Journal of Asian Natural Products Research. doi:10.1080/10286020.2021.1914597 Preclinical
    https://doi.org/10.1080/10286020.2021.1914597
  33. Abbas, M.A. and Jaffal, S.M (2019) 'ANTINOCICEPTIVE ACTION OF ONONIS SPINOSA LEAF EXTRACT IN MOUSE PAIN MODELS', Acta Poloniae Pharmaceutica - Drug Research. doi:10.32383/appdr/99291 Preclinical
    https://doi.org/10.32383/appdr/99291
  34. (2009) 'Radical scavenger and Antioxidant activities of extracts and fractions from Bulgarian Ononis spinosa L. and GC-MS analysis of Ethanol extract', The Internet Journal of Alternative Medicine. doi:10.5580/121d Preclinical
    https://doi.org/10.5580/121d
  35. Davitavyan, N. and Е.Б., Н. and Pogulyay, Y. and Khochava, M. and Мизина, П. and Адамов, Г (2024) 'STUDYING THE HYPOLYPIDEMIC ACTIVITY OF FLAVONOIDS AND ISOFLAVONOIDS OF THE ONONIS ARVENSIS L. METHODS BY IN SILICO', Problems of Biological Medical and Pharmaceutical Chemistry. doi:10.29296/25877313-2024-05-01 Preclinical
    https://doi.org/10.29296/25877313-2024-05-01
  36. Gampe, N. and Dávid, D.N. and Takács‐Novák, K. and Backlund, A. and Béni, S (2022) 'In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system', PLoS ONE. doi:10.1371/journal.pone.0265639 Preclinical
    https://doi.org/10.1371/journal.pone.0265639
  37. Pauli, G.F (2000) 'Comprehensive Spectroscopic Investigation of α-Onocerin', Planta Medica. doi:10.1055/s-2000-14895 Preclinical
    https://doi.org/10.1055/s-2000-14895
  38. Köster, J. and Strack, D. and Barz, W (1983) 'High Performance Liquid Chromatographic Separation of Isoflavones and Structural Elucidation of Isoflavone 7-O-glucoside 6″-malonates from Cicer arietinum', Planta Medica. doi:10.1055/s-2007-969907 Preclinical
    https://doi.org/10.1055/s-2007-969907
  39. Spiegler, V. and Michalak, B. and Addotey, J.N. and Saenger, T. and Jose, J. and Kiss, A.K. and Hensel, A (2019) 'Root extracts from Ononis spinosa exert anti-inflammatory activity in vitro on IL-8 and TNF-α release by inhibition of TLR-4 receptor', Planta Medica. doi:10.1055/s-0039-3399691 Preclinical
    https://doi.org/10.1055/s-0039-3399691
  40. Çoban, T. and Çitoğlu, G.S. and Yılmaz, B.S. and İşcan, M (2003) 'Antioxidant Activities of Plants Used in Traditional Medicine in Turkey', Pharmaceutical Biology. doi:10.1080/13880200390501974 Preclinical
    https://doi.org/10.1080/13880200390501974
  41. Obiștioiu, D. and Cocan, I. and Tîrziu, E. and Herman, V. and Negrea, M. and Ban-Cucerzan, A. and Neacşu, A. and Cozma, A. and Nichita, I. and Hulea, A. and Radulov, I. and Alexa, E (2021) 'Phytochemical Profile and Microbiological Activity of Some Plants Belonging to the Fabaceae Family', Antibiotics. doi:10.3390/antibiotics10060662 Preclinical
    https://doi.org/10.3390/antibiotics10060662
  42. Orlando, G. and Chiavaroli, A. and Ferrante, C. and Recinella, L. and Leone, S. and Brunetti, L. and Simone, S.C.D. and Menghini, L. and Petrucci, M. and Zengin, G. and Cesaroni, F. and Pontarelli, G. and Cindolo, L. and Neri, F (2021) 'Protective effects induced by the food supplement Fluxonorm® in the lower urinary tract', PubMed. doi:10.26355/eurrev_202104_25562 Preclinical
    https://doi.org/10.26355/eurrev_202104_25562

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.